111 Free Cash Flow 2018-2024 | YI

111 free cash flow from 2018 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
111 Annual Free Cash Flow
2023 -64.14
2022 -7.76
2021 -117.86
2020 -21.78
2019 -76.45
2018 -51.98
2017 -31.91
111 Quarterly Free Cash Flow
2024-09-30 44.40
2024-06-30 27.76
2024-03-31 15.02
2023-12-31 -64.14
2023-09-30 -34.30
2023-06-30 -39.37
2023-03-31 -17.67
2022-12-31 -7.76
2022-09-30 -12.14
2022-06-30 -14.66
2022-03-31 -10.77
2021-12-31 -117.86
2021-09-30 -58.15
2021-06-30 -41.43
2021-03-31 -39.60
2020-12-31 -21.78
2020-09-30 5.79
2020-06-30 1.99
2020-03-31 -15.81
2019-12-31 -76.45
2019-09-30 -61.68
2019-06-30 -22.26
2019-03-31 -8.84
2018-09-30 -24.18
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.050B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.870B 55.80
Tempus AI (TEM) United States $9.036B 0.00
Hims & Hers Health (HIMS) United States $8.145B 207.11
Inspire Medical Systems (INSP) United States $5.799B 180.84
IRhythm Technologies (IRTC) United States $3.407B 0.00
Privia Health (PRVA) United States $2.742B 228.50
Enovis (ENOV) United States $2.671B 17.80
Azenta (AZTA) United States $2.470B 131.83
Clover Health Investments (CLOV) United States $2.200B 0.00
Omnicell (OMCL) United States $2.084B 68.17
Schrodinger (SDGR) United States $1.827B 0.00
10x Genomics (TXG) United States $1.816B 0.00
Phreesia (PHR) United States $1.654B 0.00
Butterfly Network (BFLY) United States $0.850B 0.00
Standard BioTools (LAB) United States $0.577B 0.00
Talkspace (TALK) United States $0.524B 0.00
Fulgent Genetics (FLGT) United States $0.509B 0.00
TruBridge (TBRG) United States $0.370B 107.91
Nyxoah SA (NYXH) Belgium $0.368B 0.00
Health Catalyst (HCAT) United States $0.343B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.229B 0.00
Pulmonx (LUNG) United States $0.224B 0.00
American Well (AMWL) United States $0.165B 0.00
MDxHealth SA (MDXH) Belgium $0.090B 0.00
EUDA Health Holdings (EUDA) Singapore $0.087B 0.00
P3 Health Partners (PIII) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
CareCloud (CCLD) United States $0.056B 0.00
SHL Telemedicine (SHLT) Israel $0.047B 0.00
Outset Medical (OM) United States $0.043B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.020B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00